Despite its efficacy, combinational therapy should be the choice since standalone immune checkpoint inhibition may prove ineffective, likely due to the tumor’s low PD-L1 expression, intricate tumor–stroma interactions, and desmoplastic nature [77]. The gene discussed is CD274; the disease is neoplasm.